The Enterprise Value as of June 2026 (TTM) for Akoya Biosciences, Inc. (AKYA) is 127.81M

According to Akoya Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 127.81M. This represents a change of -28.02% compared to the average of 177.57M of the last 4 quarters.

Akoya Biosciences, Inc. (AKYA) Historical Enterprise Value (quarterly & annually)

How has AKYA Enterprise Value performed in the past?

The mean historical Enterprise Value of Akoya Biosciences, Inc. over the last ten years is 462.68M. The current 127.81M Enterprise Value has changed 2.66% with respect to the historical average. Over the past ten years (40 quarters), AKYA's Enterprise Value was at its highest in in the March 2021 quarter at 737.40M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Akoya Biosciences, Inc. (AKYA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Akoya Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Akoya Biosciences, Inc. (AKYA) Average Enterprise Value

How has AKYA Enterprise Value performed in the past?

The current Enterprise Value of Akoya Biosciences, Inc. (AKYA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Akoya Biosciences, Inc. (AKYA) Enterprise Value vs. Peers

How is AKYA’s Enterprise Value compared to its peers?

Akoya Biosciences, Inc.’s Enterprise Value is greater than Singular Genomics Systems, Inc. (109.82M), greater than The Valens Company Inc. (-670000.00), greater than NeueHealth, Inc. (-69677307.00), greater than Surface Oncology, Inc. (70.21M), greater than Lifeward Ltd. (8.31M), greater than Reneo Pharmaceuticals, Inc. (-130856584.00), greater than Zynerba Pharmaceuticals, Inc. (19.81M), greater than Achilles Therapeutics plc (-66096000.00), less than Heat Biologics, Inc. (18.12T), greater than Sigilon Therapeutics, Inc. (42.21M),

Build a custom stock screener for Akoya Biosciences, Inc. (AKYA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akoya Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Akoya Biosciences, Inc. (AKYA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Akoya Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.